[AMRX] YoY Quarter Result on 30-Sep-2018 [#Q3]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
07-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 103.17%
YoY- -74.04%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 620,040 545,557 528,593 519,294 378,283 476,487 254,733 15.97%
PBT 22,957 2,180 -2,043 -21,889 26,276 22,574 26,384 -2.29%
Tax -2,076 4,570 4,049 144 389,668 5,109 -738 18.80%
NP 9,682 -2,390 -4,237 -8,975 -265,006 6,952 26,780 -15.59%
Tax Rate 9.04% -209.63% - - -1,482.98% -22.63% 2.80% -
Total Cost 610,358 547,947 532,830 528,269 643,289 469,535 227,953 17.83%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin 1.56 -0.44 -0.80 -1.73 -70.05 1.46 10.51 -27.22%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS 0.06 -0.02 -0.03 -0.06 -2.03 0.05 0.23 -20.05%
EPS Diluted 0.06 -0.02 -0.03 -0.06 -2.03 0.05 0.23 -20.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.